fda approval tirzepatide Day 4: Zepbound (Tirzepatide – weight loss indication) Approved: November 2023 for weight management Weight Loss: Up to 22.5% in clinical trials Similar to Mounjaro, but marketed specifically for weight management FDA Approves Tirzepatide, A Potential

Brand-name Zepbound has a list price around $1,059 per month

10.1038/hr.2015.142 90 Hernandez-NavarroI.BotanaL.Diez-MataJ.TesoroL.Jimenez-GuiradoB.Gonzalez-CuchareroC.et al (2024)

The results were life-changing, but when supplies dwindled because of a worldwide shortage, she asked her doctor whether it was safe to use an unofficial version of the drug made at a compounding pharmacy

Additionally, the altered gastrointestinal motility may affect the timing of food delivery to the small intestine where natural enzymes from the pancreas act

Liraglutide remains in use for specific clinical situations

Targets both hunger and insulin pathways for faster and more effective results when your body needs more